SABBY 13G ORMP 12.31.13

Company

ORAMED PHARMACEUTICALS INC.

Filed

December 31, 2013

Accession Number

0001535610-13-000057

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →